CLINICAL EVALUATION OF PHOTOTHERAPY EFFECTIVENESS IN NEWBORNS WITH PHYSIOLOGICAL AND HEMOLYTIC JAUNDICE
Keywords:
neonatal jaundice, physiological jaundice, hemolytic jaundice, phototherapy, bilirubin, newborns, neonatal care, treatment effectivenessAbstract
Neonatal jaundice is one of the most common conditions in newborns, with potential implications for infant health if not managed properly. Physiological and hemolytic jaundice differ in etiology, bilirubin levels, and clinical progression, requiring tailored treatment approaches. Phototherapy remains the primary and safe method to reduce bilirubin levels in neonates. This study presents a clinical evaluation of phototherapy effectiveness in newborns with physiological and hemolytic jaundice. Parameters such as bilirubin reduction rate, treatment duration, clinical improvement, and possible side effects were analyzed. The results demonstrate that phototherapy is effective in both types of jaundice, with faster bilirubin reduction in physiological jaundice and longer treatment courses required for hemolytic jaundice. The findings highlight the importance of individualized treatment strategies in neonatal care.
Downloads
References
1. Maisels, M.J., McDonagh, A.F. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358(9):920–928.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
3. Bhutani, V.K., Johnson, L. Screening for severe neonatal hyperbilirubinemia – time for action. Pediatrics. 2006;117(4):1169–1174.
4. Watchko, J.F., Tiribelli, C. Bilirubin-induced neurologic damage—mechanisms and management approaches. N Engl J Med. 2013;369:2021–2030.
5. Kaplan, M., Hammerman, C. Hemolytic disease of the newborn and hyperbilirubinemia: Current concepts. Pediatr Clin North Am. 2005;52(2):363–383.
6.
